Can we save our resources with half-body-18F-FDG-PET-CT rather than whole-body, in the management of head & neck cancers? by unknown
POSTER PRESENTATION Open Access
Can we save our resources with
half-body-18F-FDG-PET-CT rather than whole-body,
in the management of head & neck cancers?
LI Sonoda*, A Lakhani, S Ghosh-Ray
From International Cancer Imaging Society (ICIS) 14th Annual Teaching Course
Heidelberg, Germany. 9-11 October 2014
Introduction
18F-FDG PET-CT plays a significant role in the man-
agement of head and neck (H&N) malignancies. There
have been recent suggestions that half-body (above dia-
phragm) PET-CT may be sufficient for the management
of H&N cancer patients. This study aims to determine if
half-body PET-CT is a safe practice option, or should
we stick to whole-body PET-CT.
Methods
A 6-year-period retrospective analysis of 729 consecutive
PET-CT scans of H&N cancer patients was performed
in order to record the incidence of below-diaphragm
metastases and below-diaphragm synchronous primary
malignancies. The four main indications of PET-CT in
H&N cancers are; pre-treatment staging of high-risk of
disseminated disease, metastatic cervical lymphadenopa-
thy with unknown primary, assessment of therapeutic
response and detection of recurrence/relapse.
Results
A total of 664 squamous cell carcinoma (SCC) and 65 naso-
pharyngeal carcinoma (NPC) cases were studied. 35/729
(4.8%) of cases showed below-diaphragm metastases (liver,
renal, adrenal, retroperitoneal and lumbar vertebral metas-
tases), 24/664 (3.3%) by SCC and 11/65 (16.9%) by NPC.
52/729 (7.1%) cases showed synchronous primary
malignancies, of which 32 (4.4%) were below-diaphragm
(colonic, pancreatic, bladder cancers and retroperitoneal
lymphoma).
In total, 84/729 (11.5%) H&N cases had either below-
diaphragm metastases or below-diaphragm synchronous
primary malignancies.
Conclusion
A significant proportion of H&N patients, over 10%, have
either below-diaphragm metastases or below-diaphragm
synchronous primary malignancies. Half-body (above dia-
phragm) PET-CT would have missed these lesions, leading
to mis-staging of disease and mis-management of patients.
It is important to keep whole-body PET-CT in practice in
the management of H&N cancers. This is more so in the
management of NPC compared to SCC.
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